Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Psoriasis × Folic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 5 Neoplasm Metastasis 4 Recurrence 3 Head and Neck Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Diseases 1 Smoking 1 Psoriasis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, B-Cell 1 Laryngeal Diseases 1 Hyperbilirubinemia 1 Fallopian Tube Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

tofacitinib 7 Etanercept 4 Methotrexate 2 Adalimumab 2 secukinumab 1 baricitinib 1 apremilast 1 Vitamin D 1 Vaccines 1 Saline Solution 1 Herpes Zoster Vaccine 1 Folic Acid 1 Fish Oils 1 Fatty Acids, Omega-3 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cholecalciferol 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00932113 2017-08-31

MOA

Tufts Medical Center

Phase 4 Completed

33 enrolled 11 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡